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Bożena Muszyńska1, Monika Dąbrowska2* , Małgorzata Starek2, Paweł Żmudzki3,
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Pollution of the environment with inorganic and organic substances is one of the main
problems in the world. For this reason, it is necessary to conduct researches for effective
methods of biodegradation of xenobiotics, including drugs whose unmetabolized forms
are introduced into the environment, especially into water. One possible solution to this
problem may be the use of white rot fungi, such as Lentinula edodes. This is an edible
species used in medicine because of its beneficial anti-cancer, hypocholesterolemic,
hypotensive, hypoglycemic and antioxidant effects. Due to the fact that the mycelium
of L. edodes produces enzymes with oxidizing properties that can degrade xenobiotics.
The aim of the work was verification if in vitro cultures of L. edodes can be used for
bioremediation of non-steroidal, anti-inflammatory drug: piroxicam. For this purpose,
the in vitro culture of L. edodes was derived and the mycelial cultures of this species
enriched with piroxicam were analyzed. The biodegradation pathway of piroxicam by
L. edodes mycelium was carried out by the UPLC/MS/MS method. The degradation
process of piroxicam was found to affect primarily the linker between the thiazine
and the piperidine ring, leading to its oxidation and cleavage. Additionally, oxidation
of the benzothiazine moiety was observed, leading to hydroxylation and oxidation
of the phenyl ring as well as oxidation of the thiazine ring leading to partial or
complete removal of the sulfonamide moiety. It seems that the degradation process
led finally to 2-hydroxybenozquinone, which may be further oxidized to inorganic
compounds. What’s more, concentration of piroxicam in in vitro cultures of L. edodes
was not correlated with effectiveness of biodegradation of this compound – on each
experimental series, the level of degradation was the same. The results confirm the
possibility of using the investigated L. edodes mycelium for remediation of piroxicam.
Keywords: bioremediation, edible mushroom, Lentinula edodes, piroxicam, UPLC/MS/MS analysis
INTRODUCTION
Pollution of the environment with inorganic and organic substances has become one of the
main problems in the world. The main goal is to look for an effective method of biodegradation
of xenobiotics, including drugs whose excess or unmetabolized forms are introduced into the
environment (Das, 2005; Kulshreshtha et al., 2014; Kryczyk et al., 2017).
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Pharmaceuticals have an important role in the treatment and
prevention of disease in humans and animals. Unfortunately,
they can also have unintended effects on living organisms
in the environment. If possible, side effects on human and
animal health are usually investigated, the study of potential
environmental impact has only recently become a subject of
interest for researchers. However, metabolism products or the
combination of various biologically active compounds may have
unpredictable effects.
The main source of contamination of water or soil
with medicines are excrements. After being transported
to municipal sewage systems, they reach the environment.
Active substances may appear unchanged or in the form of
metabolites. Wastewater treatment plants essentially remove
solids and organic substances, while recalcitrant pollutants are
often neglected.
Studies conducted all over the world indicate that NSAIDs are
present in seawater, surface water and sewage (Lolic et al., 2015;
Mainero Rocca et al., 2015). The presence of such drugs, even at
low concentrations, can have a significant impact on water and
land systems (Bácsi et al., 2016).
Piroxicam is a non-steroidal anti-inflammatory agent, widely
used for chronic inflammatory conditions, particularly in
treatment of rheumatoid arthritis, osteoarthritis, ankylosing
spondylitis, pain in musculoskeletal disorders, acute gout and
postoperative and postpartum pain. It characterized by low
solubility and high permeability, therefore, adverse effects were
reported when large doses are taken over a long period of time
(Saganuwan and Orinya, 2016).
Piroxicam is a drug which mechanism of action is
non-selective inhibition of cyclooxygenases. The ease with
which a piroxicam molecule can transform from one prototropic
form to another, depending on the environment conditions. This
can be associated with the presence of hydrophobic chains with
different lengths and surface charges in the environment which
affects the interaction of piroxicam with micelles. Some studies
show the impact of these factors on determining this balance
(Chakraborty and Sarkar, 2005).
In the available literature there are works on the stability
of piroxicam under different reaction environment conditions
(Lemp et al., 2001; Puthli and Vavia, 2009; Starek et al.,
2009; Aminuddin et al., 2011; Modhave et al., 2011). They
indicate significant degradation of the molecule under hydrolytic,
oxidative and photo-neutral conditions, and at the same time
stability in dry heat and exposure to light in the solid
state. The advanced degradation of piroxicam by oxidation
(ozone or H2O2/O3 treatment) has been rarely explored (Feng
et al., 2015). Lianou et al. (2018) presented a sonochemical
oxidation of piroxicam with proposition of a degradation
pathways. Authors point to ultrasonic irradiation as a promising
technology with relatively high efficiency, but the scale of the
process should still be analyzed in order to be able to be
used commercially.
Some studies of the level of pharmaceuticals in wastewater
from treatment, including many NSAIDs such as ibuprofen
and naproxen, may lead to the finding of their toxic
concentration in relation to fishes (Qun et al., 2008).
Prolonged exposure of fish to environmentally harmful
concentrations of drugs may bioaccumulate and deteriorate
their health (Schwaiger et al., 2004). It shows how
important research is on the possibilities of eliminating
pollutants from the environment. In some cases, it turned
out that metabolites are more toxic than the original
compound, which is an additional problem in remediation
(van Leeuwen et al., 2011).
The natural ability of mushroom to neutralize toxic
substances from their environment encouraged scientists
to evaluate their use in biodegradation of xenobiotics in
in vitro conditions. Biodegradation ability is connected with
synthesis of non-selective enzymes in hyphae, especially
the ones which can be excreted extracellularly and high
efficiency in environmental cleansing processes is also caused
by rapid growth, production of large amounts of biomass
and widespread occurrence of hyphae in the environment
(Ashoka et al., 2002; Ma and Zhai, 2014). The processes of
mycoremediation use different mechanisms than those found
in bacteria. The main advantage is that they do not require
initial preparation for specific contamination (Asamudo
et al., 2005). Lang describes that white rot fungi (WRF) show
remarkable abilities to transform resistant impurities such as
polycyclic aromatic hydrocarbons to non-toxic products (Lang
et al., 1995). The main mechanism of degradation catalyzed
by white rot fungi concerns the degradation of lignin in the
natural environment. Extracellular lignin modifying enzymes
(LMEs) have low substrate specificity, so they are capable of
mineralizing a large number of various highly resistant organic
impurities structurally related to lignin (Novotný et al., 2004;
Kaneda et al., 2008; Wong, 2009).
Thanks to this ability, it is possible to use mushroom
cultures to remove organic pollutants from the environment.
For this reason, the edible mushroom L. edodes belonging
to the WRF species was selected in this study. L. edodes is
intensively studied due to the presence of compounds with
therapeutic effects such as anti-cancer, hypocholesterolemic,
hypotensive, hypoglycemic, antioxidant antifungal and
antibacterial in fruiting bodies (Casaril et al., 2011; Mleczek
et al., 2017; Muszyńska et al., 2017). Some of these
compounds are well characterized and used, e.g., lentinan,
lentinacin, eritadenin. The most studied active substance
isolated from L. edodes is pure β-(1,3)-D-glucan known
as lentinan. As a result of in vitro and in vivo studies,
the extracts of L. edodes and lentinan have been shown to
have antitumor activity and for this reason preparations
that contain them are used in conventional oncological
therapy (Fulushima et al., 2001).
Due to the fact that mycelium L. edodes produces enzymes
with oxidizing properties that can degrade xenobiotics, the aim
of the work was to use this edible species for the human body
and the environment to remedy them from the commonly
used non-steroidal anti-inflammatory drug piroxicam. For this
purpose, the in vitro culture of L. edodes was derived, followed
by shaking mycelial cultures of this species to which piroxicam
was added. The piroxicam biodegradation pathway was
analyzed by UPLC/MS/MS.
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MATERIALS AND METHODS
Reagents
The chemicals: glucose, maltose extract, casein hydrolyzate,
L-asparagine, adenine, B1 and B6 vitamins, agar, yeast
extract were purchased from Sigma-Aldrich (St. Louis, MO,
United States). NH4Cl, KH2PO4, MgSO4·7H2O, CaCl2·6H2O,
FeCl3, MnSO4·H2O, ZnSO4·7H2O were bought from
PPHGolpharm (Kraków, Poland). HPLC grade methanol
and dichloromethane came from Merck (Darmstadt, Germany).
Water (quadruple-distilled) with a conductivity of less than
1 µS cm−1 was obtained using an S2-97A2 distillation apparatus
(ChemLand, Stargard Szczeciński, Poland). Reference substance
of piroxicam was from FIS (Vicenza, Italy).
Mushroom Material
The fruiting bodies of L. edodes (Berk.) Pegler of commercial
origin, purchased at a supermarket in Poland. Taxonomic
identification was based on the MycoKey 4.11 by Muszyńska.
Representative samples of the material are kept at the
Department of Pharmaceutical Botany UJ CM (Kraków, Poland).
Some of the young sporocarps of L. edodes were used to
develop in vitro culture. Fragments of the hymenial part of
sporocarps with an area of approx. 2 mm2 were used. The
explants were degreased with 70% alcohol. After several rinsing
with sterile redistilled water, the sporocarps fragments were
transferred to the BD Sabouraud Agar with chloramphenicol
(laminar airflow) medium. The solid cultures were incubated
in a thermostat (ST500/B/40 Pol-Eko-Apparatus) at 23◦C for
2 weeks (Picture 1). Microscopic analysis of obtained mycelium
1http://www.mycokey.com
PICTURE 1 | Lentinula edodes in vitro culture on solid medium (picture made
by Bożena Muszyńska).
of L. edodes was carried out by Muszyńska. It showed a
homogeneous nature of hyphae, free from contamination with
other strains of fungi or bacteria. In the microscopic image,
numerous branches and transverse walls were visible as well as
the dikaryotic phase. Representative petri plates with mushroom
material named LES/KB2 are kept at the Department of
Pharmaceutical Botany UJ CM (Kraków, Poland).
Cultures from the solid medium were used to establish
experimental cultures cultivated on the modified liquid Oddoux
medium (Oddoux, 1957). The initial inoculum from the solid
medium was 0.1 g. The cultures were shaken at a rate of 140 rpm
(ALTEL, Poland) and incubated at a temperature of 23 ± 2◦C
under a photoperiod (10-h light, 900 lx, and 14-h dark). The
agitated liquid cultures of L. edodes were maintained for 2 weeks,
and then subcultured.
Experimental in vitro Culture
Mycelium of L. edodes was passaged to Erlenmayer flasks
containing 250 mL of liquid Oddoux medium with addition of
piroxicam in daily dosages used by human (10, 20, and 80 mg).
The flasks were put into rotary shaker (ALTEL, Poland) with 140
RPM for 2 weeks in 23 ± 2◦C under a photoperiod (10-h light,
900 lx, and 14-h dark). After 14 days of incubation, biomass was
separated from the medium, rinsed with redistilled water and
prepared for lyophilization as well as separated liquid medium.
Then, the obtained mycelium from in vitro cultures and culture
media were subjected to the lyophilization process (Freezone 4.5,
Labconco) (Picture 2).
Sample Preparation
The powdered in a mortar mushroom materials (mycelium from
in vitro cultures on media containing piroxicam and culture
PICTURE 2 | Experimental in vitro culture of L. edodes with addition of
piroxicam in liquid Oddoux medium (picture made by Bożena Muszyńska).
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media) at 5 g were extracted with a mixture of methanol and
dichloromethane in ratio: 75:25 (v/v) in an ultrasonic bath at
49 kHz for 30 min (Sonic-2, Polsonic). Merged extracts (300 mL)
were concentrated to dryness using a rotary vacuum evaporator
at 22± 2◦C, and were subjected to UPLC/MS/MS analysis.
UPLC/MS/MS Analysis
The UPLC-MS/MS system consisted of a Waters ACQUITY R©
UPLC R© (Waters Corp., Milford, CT, United States) coupled
to a Waters TQD mass spectrometer (electrospray ionization
mode ESI-tandem quadrupole). Chromatographic separations
were carried out using the Acquity UPLC BEH C18 column
(2.1 × 100 mm, 1.7 µm particle size), equipped with Acquity
UPLC BEH C18 VanGuard pre-column (2.1 × 5 mm, 1.7 µm
particle size). The column was maintained at 40◦C, and eluted
under gradient conditions using from 95 to 0% of eluent A over
10 min; a flow rate of 0.3 mL min−1. Eluent A: water/formic
acid (0.1%, v/v); eluent B: acetonitrile/formic acid (0.1%, v/v).
Chromatograms were recorded using Waters eλ PDA detector.
Spectra were analyzed in 200–700 nm range with 1.2 nm
resolution and sampling rate 20 points s−1. MS detection settings
of Waters TQD mass spectrometer were: source temperature
150◦C, desolvation temperature 350◦C, desolvation gas flow rate
600 L h−1, cone gas flow 100 L h−1, capillary potential 3.00 kV,
cone potential 30 V. Nitrogen was used for both nebulizing and
drying gas. The data were obtained in a scan mode ranging from
50 to 1000 m/z in time 0.5 s intervals; 8 scans were summed up to
get the final spectrum. Collision activated dissociations analyses
were carried out with the energy of 40 eV. Consequently, the ion
spectra were obtained by scanning from 50 to 500 m/z range. Data
acquisition software was MassLynx V 4.1 (Waters).
RESULTS AND DISCUSSION
A variety of methods were used to remove drug contaminants
from wastewater and drinking water treatment, such as
sonochemical degradation of ibuprofen (Xiao et al., 2014),
naproxen (Im et al., 2013), diclofenac (Naddeo et al., 2013).
Other ways to removing possible pollutants are phytoremediation
or mycoremediation (Nowrotek et al., 2016; Topal et al., 2016;
Rodríguez-Espinosa et al., 2018).
Researches about usage of WRF for wastewater treatment have
been conducting for many years (Pointing, 2001; Lamrood and
Ralegankar, 2013). The ability of the WRF to degrade various
pharmaceutical compounds, which can be transmitted to the
environment and thus be potentially harmful, has also been
reported (Tsujiyama et al., 2013; Riggins and Gregory, 2015;
Eldridge et al., 2017; Muszyńska et al., 2018b).
Based on research data there are some works about using
fungi in the process of decomposition of polycyclic NSAIDs
(Suryanarayanan et al., 2012; Domaradzka et al., 2015). Complete
degradation was described only for olsazine (Razo-Flores et al.,
1997). The first step of the transformation is most often
hydroxylation catalyzed by cytochrom P-450 monooxygenases,
or oxygenation by laccases and three peroxidases: lignin
peroxidase, manganese-dependent peroxidase and versatile
peroxidase manganese-dependent peroxidase. Applied species
were able to dechlorinate halogenated aromatics (Marco-
Urrea et al., 2009). Gonda et al. (2016) presented the first
FIGURE 1 | UPLC-DAD chromatograms obtained for: (A) Oddoux medium from in vitro culture of L. edodes; (B) Oddoux medium from in vitro culture of L. edodes
with addition of piroxicam (20 mg/250 mL) in the beginning of logarithmic phase of mycelium growth.
Frontiers in Microbiology | www.frontiersin.org 4 February 2019 | Volume 10 | Article 313
fmicb-10-00313 February 19, 2019 Time: 17:5 # 5
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research about fungal transformation of piroxicam and diflunisal.
These authors discussed the ability of the species used to
biotransformation of chosen medicines, and the possibility of
using high concentrations of these substances and their chemical
similarity. Compounds produced by fungi (e.g., Aspergillus
nidulans, Bipolaris tetramera) were similar to metabolites, which
can be less or more toxic compared to the original substances.
During oxidation the polarity of compounds increases, which
may affect their less bioaccumulation. However, it may happen
that thanks to fungal enzymes, this process can be increased.
From the investigated drugs, piroxicam was the most resistant to
used strains (Gonda et al., 2016).
TABLE 1 | Proposed structures and fragmentation pattern of piroxicam by mycelium from in vitro cultures of Lentinula edodes.
Compound RT [min] [M+H+] Fragmentation
ions
Structure Scheme
PP-1 2.58 180.0∗ 116.0
PP-2 2.66 209.0∗ 109.0, 137.0,
165.0
PP-3 3.11 198.0∗ 132.0
PP-4 4.23 303.0 95.1, 101.0, 121.0,
181.0, 209.0
piroxicam 5.05 332.1 78.0, 95.1, 121.0,
164.1, 194.0,
210.0, 238.0
PP-5 5.84 107.0∗ 79.0
∗[M–H2O]+
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Jimenez et al. (2018) described biological, photochemical and
thermal degradation of three oxicams in samples river water.
Obtained results indicated that the direct sunlight irradiation
promoted a fast degradation of drugs, while the chemical
reactions in solution were less important. After about month
several degradation products were found. Authors proposed
their structures and pathways of degradation, created by
photochemical reactions as the main reason of the degradation
of the oxicams in water, except hydrolysis.
Continuing the implementation of the subject our team
(Dąbrowska et al., 2018) made research project about the ability
of L. edodes’s mycelium from in vitro cultures to degrade
antibiotics. Authors showed that the examined mycelia take
short time duration to remove the cefuroxime axetil from
the medium. An observed mycoremediation process can be
used as an alternative to other methods for remediation
cephalosporins contamination.
In presented experiment good biomass growth for L. edodes
could be obtained from agitating liquid cultures on the modified
Oddoux medium and on the same medium with addition of
piroxicam. The dynamics of mycelium growth in liquid Oddoux
medium did not differ from that registered in earlier researches,
and with addition of piroxicam was in the same level (Muszyńska
et al., 2015, 2018a). The addition of piroxicam to medium
lead to increase of L. edodes biomass in their culture in vitro
(average to 1.2 g dry weight per 1 L of mushroom medium).
However, growth stimulation was not dependent on applied
dose of piroxicam.
Analysis of the extracts of the medium and mushroom
mycelium with no addition of piroxicam showed no peaks
on UV chromatogram thus all the compounds observed
on the chromatograms of the extracts of the mushroom
materials with added drug were most probably products of its
biodegradation (Figure 1).
The identification of the degradation products of piroxicam
was performed on a basis of UPLC/MS analysis and supported
with fragmentation patterns obtained from MS/MS experiments.
The proposed structures of the degradation products are
shown in Table 1. The proposed fragmentation patterns
of piroxicam and its degradation products are shown
on Figure 2.
The degradation process was found to affect primarily the
linker between the thiazine and the piperidine ring, leading
to its oxidation and cleavage. Additionally, oxidation of the
benzothiazine moiety was observed, leading to hydroxylation
and oxidation of the phenyl ring (PP-2, PP-3, and PP-5), as
well as oxidation of the thiazine ring leading to partial (PP-4)
or complete removal (PP-2 and PP-5) of the sulfonamide
moiety (Table 1). The molecular ion ([M+H+]) peak of
m/z 332.1 fragmented into 7 ions of m/z 78.0, 95.1, 121.0,
164.1, 194.0, 210.0, 238.0. Based on the fragmentation ions for
obtained degradation products (PP-1 to PP-5) and the available
literature data, we have attempted to identify possible ways of
degradation of piroxicam in fungal environment. It seems that
the degradation process led finally to 2-hydroxybenozquinone,
which may be further oxidized yielding inorganic compounds.
What more piroxicam biodegradation was on the same level for
used different concentration of piroxicam (10; 20; 80 mg per
250 mL of medium), what may suggest, that the ability of the
mushroom to degrade the drug was not exceeded even in the
highest concentration of piroxicam.
The presence of electron withdrawing functional groups,
such as amide, carboxylic, halogen, and nitro group generates
an electron deficiency and thus renders the compounds less
FIGURE 2 | Proposed fragmentation pattern of piroxicam by mycelium from in vitro cultures of L. edodes.
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susceptible to oxidative catabolism. Whereas while
electron-donating functional groups, such as amine, hydroxyl,
alkoxy, make the molecules more susceptible to electrophilic
attack by oxygenases (Yang et al., 2013). In this review
authors reported many cases of bioremediation for drugs
form various classes, quoting source works. To our best
knowledge such studies for piroxicam have not been
carried out yet. A specific class of enzymes, commonly
secreted by WRF, called LMEs, is of particular interest for
biodegradation of pharmaceuticals. The most studied LMEs
are glycosylated heme-containing peroxidases, lignin and
manganese peroxidases, and a copper-containing phenoloxidase
and laccase (Pointing, 2001; Janusz et al., 2017). LMEs are
primarily oxidoreductases that catalyze the flow of electrons
from one substrate to another, and work by generating
free radicals that randomly react with the lignin polymer,
breaking covalent bonds and releasing phenolic compounds.
Thanks to such mechanism, advanced oxidation reactions
take place. The lignin degrading-system is extracellular,
non-stereoselective and non-specific, able to cleave the
carbon-carbon and carbon-oxygen bonds, regardless of the
conformation of the chiral carbon of lignin (Fernando and
Aust, 1994). This feature is partly due to highly reactive
free radical degradation mechanisms that are ideal for the
biodegradation of organic pollutants in the environment.
Gonda et al. (2016) described a degradation pathway of
piroxicam based on fragmentation pattern developed by other
authors. Presented fragmentation showed, that the pyridine
ring was hydroxylated, and a new compound was identified
as hydroxypiroxicam.
The results obtained in presented research, are in accordance
with this observation, since pyridine and thiazine moieties, which
are electron rich regions of the piroxicam molecule, were readily
degraded. At the same time phenyl ring was found to be quite
stable and underwent only partial degradation via oxidation
to 2-hydroxyquinone.
Results received under described work indicate on a high level
of the degradation degree of examined drug by analyzed mycelia.
These information shows necessity for further studies, which are
still indispensable in order to have a comprehensive knowledge
of ability of WRF to remediate pharmaceuticals.
CONCLUSION
Pharmaceuticals in the environment can potentially cause to the
formation of resistant strains of bacteria as well as recalcitrant
toxins. Presented pilot tests showed that the examined mycelium
from in vitro cultures of L. edodes mushroom take short time
duration to remove the piroxicam from the medium, and thus
mycoremediation can be used as an alternative to other methods
for remediating contamination of this compound. Thanks to
reproducible culture conditions, mycelium from in vitro cultures
used in the experiment allow the monitoring of the accumulation
and biodegradation of piroxicam from the media and the
determination of the degree of bioaccumulation, and this further
allows the selection of species for environmental remediation
from this compound which are detrimental to living organisms.
The results confirm the possibility of the use of the investigated
mycelia of L. edodes from in vitro cultures, in remediation of
piroxicam.
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Janusz, G., Pawlik, A., Sulej, J., Świderska-Burek, U., Jarosz-Wilkołazka, A., and
Paszczyński, A. (2017). Lignin degradation: microorganisms, enzymes involved,
genomes analysis and evolution. FEMS Microbiol. Rev. 41, 941–962. doi: 10.
1093/femsre/fux049
Jimenez, J. J., Munoz, B. E., Sanchez, M. I., and Pardo, R. (2018). Forced and long-
term degradation assays of tenoxicam, piroxicam and meloxicam in river water.
Degradation products and adsorption to sediment. Chemosphere 191, 903–910.
doi: 10.1016/j.chemosphere.2017.10.056
Kaneda, M., Rensing, K. H., Wong, J. C. T., Banno, B., Mansfield, S. D., and
Samuels, A. L. (2008). Tracking monolignols during wood development in
lodgepole pine. Plant Physiol. 147, 1750–1760. doi: 10.1104/pp.108.121533
Kryczyk, A., Piotrowska, J., Sito, M., Sułkowska-Ziaja, K., Dobosz, K., Opoka, W.,
et al. (2017). Remediation capacity of Cd and Pb ions by mycelia of Imleria
badia, Laetiporus sulphureus and Agaricus bisporus in vitro culture. J. Environ.
Sci. Health B 52, 617–622. doi: 10.1080/03601234.2017.1330068
Kulshreshtha, S., Mathur, N., and Bhatnagar, P. (2014). Mushroom as a product
and their role in mycoremediation. AMB Express 4:29. doi: 10.1186/s13568-
014-0029-8
Lamrood, P. Y., and Ralegankar, S. D. (2013). Biosorption of Cu, Zn, Fe, Cd, Pb
and Ni by non-treated biomass of some edible mushrooms. Asian J. Exp. Biol.
Sci. 4, 190–195.
Lang, E., Eller, I., Kleeberg, R., Martens, R., and Zadrazil, F. (1995). “Interaction
of white rot fungi and microorganisms leading to biodegradation of soil
pollutants,” in Proceedings of the 5th International FZK/ TNo Conference on
Contaminated Soil. 30th Oct- 5Nov, Maustrient, Amsterdam. doi: 10.1007/978-
94-011-0421-0_111
Lemp, E., Zanocco, A. L., and Gunther, G. (2001). Sentilized photoxygenation of
piroxicam in neat solvents and solvent mixtures. J. Photochem. Photobiol. B 31,
165–170. doi: 10.1016/S1011-1344(01)00265-2
Lianou, A., Frontistis, Z., Chatzisymeon, E., Antonopoulou, M., Konstantinou, I.,
and Mantzavinos, D. (2018). Sonochemical oxidation of piroxicam drug: effect
of key operating parameters and degradation pathways. J. Chem. Technol.
Biotechnol. 93, 28–34. doi: 10.1002/jctb.5346
Lolic, A., Paíga, P., Santos, L. H. M. L. M., Ramos, S., and Correia Mand
Delerue-Matos, C. (2015). Assessment of non-steroidal anti-inflammatory and
analgesic pharmaceuticals in seawaters of North of Portugal: occurrence and
environmental risk. Sci. Total Environ. 508, 240–250. doi: 10.1016/j.scitotenv.
2014.11.097
Ma, J., and Zhai, G. (2014). Antibiotic contamination: a global environment issue.
J. Bioremed. Biodeg. 5, 5–6. doi: 10.3390/ijerph15091942
Mainero Rocca, L., Gentili, A., Caretti, F., Curini, R., and Pérez-Fernández, V.
(2015). Occurrence of non-steroidal anti-inflammatory drugs in surface waters
of central Italy by liquid chromatography–tandem mass spectrometry. Int. J.
Environ. Anal. Chem. 95, 685–697. doi: 10.1080/03067319.2015.1046059
Marco-Urrea, E., Perez-Trujillo, M., Vicent, T., and Caminal, G. (2009). Ability
of white-rot fungi to remove selected pharmaceuticals and identification of
degradation products of ibuprofen by Trametes versicolor. Chemosphere 74,
765–772. doi: 10.1016/j.chemosphere.2008.10.040
Mleczek, M., Siwulski, M., Rzymski, P., Niedzielski, P., Gąsecka, M., Jasinska, A.,
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